In other countries
The same active substances on other registers, the same brand first.
- NevanacBrazil · Novartis Biociencias S.ASame brand
- NevanacBrazil · Alcon Laboratórios do Brasil Ltda.Same brand
- NEVANAC 1 mg/ml COLIRIO EN SUSPENSIONSpain · 1,0 mg · colirio en suspensión · Novartis Europharm LimitedSame brand
- NEVANAC 1mg/ml colirio en suspensionSpain · 1 mg · colirio en suspensión · Alcon Laboratories Ltd (Uk)Same brand
- NEVANAC 3mg/ml colirio en suspensionSpain · 3,0 mg/ml · colirio en suspensión · Novartis Europharm LimitedSame brand
- NevanacEuropean Union · Novartis Europharm LimitedSame brand
- NevanacCroatiaSame brand
- NevanacItaly · Collirio, sospensione · Novartis Europharm LimitedSame brand
- Nevanac 1 mg/ml oogdruppels, suspensieNetherlands · Oogdruppels, suspensie · Novartis Europharm LimitedSame brand
- Nevanac 3 mg/ml oogdruppels, suspensieNetherlands · Oogdruppels, suspensie · Novartis Europharm LimitedSame brand
- NEVANAC 1 mg/mlRomania · 1mg/ml · pic. oft. susp. · Novartis Europharm LimitedSame brand
- NEVANAC 1mg/mlRomania · 1mg/ml · pic. oft. susp. · Novartis Europharm LimitedSame brand
- NEVANAC 1mg/mlRomania · 1mg/ml · pic. oft. susp. · Alcon Laboratoires (UK) LTDSame brand
- Nevanac®Serbia · 1mg/mL · kapi za oči, suspenzija · PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd)Same brand
- Nevanac Eye DropSaudi Arabia · Alcon CouvreurSame brand
- Nevanac® Eye Drops Suspension 1 mg/mlSingapore · 1.0 mg/ml · suspension, sterile · Novartis (Singapore) Pte LTDSame brand
- NevanacUnited States · 0.1% · suspension/drops · Harrow EyeSame brand
- IlevroUnited States · 0.3% · suspension/drops · Harrow EyeSame form
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Health Canada, Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada · Added 13 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Nepafenac
- Strength
- 0.1 % / W/V
- Dosage form
- Suspension
- Route
- Ophthalmic
- Register
- Canada (Health Canada)
- Status
- Marketed
- Authorised
- 21 Aug 2008
- Registration
- DIN 02308983
- Marketing authorisation holder
- Novartis Pharmaceuticals Canada INC
- ATC code
- S01BC10
- Group
- Sensory organs
- Supply
- PRESCRIPTION